Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2

被引:6
|
作者
Lee, G-h. [1 ]
Park, S-h. [1 ]
Song, B-m. [1 ]
Kim, D-m. [1 ]
Han, H-j. [1 ]
Park, J-y. [1 ]
Jo, Y-w. [2 ]
Hwang, M-y. [2 ]
Sim, K-t. [2 ]
Kang, S-m. [1 ,3 ]
Tark, D. [1 ,3 ]
机构
[1] Jeonbuk Natl Univ, Korea Zoonosis Res Inst, Lab Infect Dis Prevent, Iksan, South Korea
[2] Natl Inst Environm Res, Div Chem Res, Incheon Gwangyeogsi, South Korea
[3] Jeonbuk Natl Univ, Korea Zoonosis Res Inst, Lab Infect Dis Prevent, Iksan 54531, South Korea
关键词
SARS-CoV-2; Disinfectants; Virucidal efficacy; Cytotoxicity; QUATERNARY AMMONIUM-COMPOUNDS; HYDROGEN-PEROXIDE; MOUTH-DISEASE; CITRIC-ACID; DNA DAMAGE; INACTIVATION; SURFACE; VIRUS; SPECTRUM; ETHANOL;
D O I
10.1016/j.jhin.2022.09.011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Disinfection is one of the most effective ways to block the rapid transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Due to the prolonged coronavirus disease 2019 (COVID-19) pandemic, disinfectants have become crucial to prevent person-to-person transmission and decontaminate hands, clothes, facilities and equipment. However, there is a lack of accurate information on the virucidal activity of commercial disinfectants.Aim: To evaluate the virucidal efficacy of 72 commercially available disinfectants con-stituting 16 types of ingredients against SARS-CoV-2. Methods: SARS-CoV-2 was tested with various concentrations of disinfectants at indicated exposure time points as recommended by the manufacturers. The 50% tissue culture infectious dose assay was used to calculate virus titre, and trypan blue staining and CCK-8 were used to assess cell viability after 3-5 days of SARS-CoV-2 infection. Findings: This study found that disinfectants based on 83% ethanol, 60% propanol/etha-nol, 0.00108-0.0011% sodium dichloroisocyanurate and 0.497% potassium perox-ymonosulfate inactivated SARS-CoV-2 effectively and safely. Although disinfectants based on 0.05-0.4% benzalkonium chloride (BAC), 0.02-0.07% quaternary ammonium compound (QAC; 1:1), 0.4% BAC/didecyldimethylammonium chloride (DDAC), 0.28% benzethonium chloride concentrate/2-propanol, 0.0205-0.14% DDAC/polyhexamethylene biguanide hydrochloride (PHMB) and 0.5% hydrogen peroxide inactivated SARS-CoV-2 effectively, they exhibited cytotoxicity. Conversely, disinfectants based on 0.04-4% QAC (2:3), 0.00625% BAC/DDAC/PHMB, and 0.0205-0.14% and 0.0173% peracetic acid showed approximately 50% virucidal efficacy with no cytotoxicity. Citric acid (0.4%) did not inactivate SARS-CoV-2.Conclusion: These results indicate that most commercially available disinfectants exert a disinfectant effect against SARS-CoV-2. However, re-evaluation of the effective concen-tration and exposure time of certain disinfectants is needed, especially citric acid and peracetic acid. 2022 The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:12 / 22
页数:11
相关论文
共 50 条
  • [1] Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2
    Satarker, Sairaj
    Nampoothiri, Madhavan
    ARCHIVES OF MEDICAL RESEARCH, 2020, 51 (06) : 482 - 491
  • [2] Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2
    Ghosh, Santosh K.
    Weinberg, Aaron
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [3] Acute Blindness as a Complication of Severe Acute Respiratory Syndrome Coronavirus-2
    Mabrouki, Fatima Zahra
    Sekhsoukh, Rachid
    Aziouaz, Faiza
    Mebrouk, Yassine
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [4] Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2
    Braxton, Alicia M.
    Creisher, Patrick S.
    Ruiz-Bedoya, Camilo A.
    Mulka, Katie R.
    Dhakal, Santosh
    Ordonez, Alvaro A.
    Beck, Sarah E.
    Jain, Sanjay K.
    Villano, Jason S.
    COMPARATIVE MEDICINE, 2021, 71 (05) : 1 - 13
  • [5] Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2
    Meister, T. L.
    Todt, D.
    Bruggemann, Y.
    Steinmann, J.
    Banava, S.
    Brill, F. H. H.
    Pfaender, S.
    Steinmann, E.
    JOURNAL OF HOSPITAL INFECTION, 2022, 120 : 9 - 13
  • [6] Prevalence of severe acute respiratory syndrome Coronavirus-2 among the young people and association between diabetes, hypertension, and severe acute respiratory syndrome Coronavirus-2
    Akter, Aklima
    Tabassum, Nafisa
    Rahman, Arifur
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2021, 5 (02): : 134 - 138
  • [7] Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2
    Trombetta, Bianca A.
    Kandigian, Savannah E.
    Kitchen, Robert R.
    Grauwet, Korneel
    Webb, Pia Kivisaekk
    Miller, Glenn A.
    Jennings, Charles G.
    Jain, Sejal
    Miller, Samara
    Kuo, Yikai
    Sweeney, Thadryan
    Gilboa, Tal
    Norman, Maia
    Simmons, Daimon P.
    Ramirez, Christopher E.
    Bedard, Melissa
    Fink, Catherine
    Ko, Jina
    Peralta, Esmarline J. De Leon
    Watts, Gerald
    Gomez-Rivas, Emma
    Davis, Vannessa
    Barilla, Rocky M.
    Wang, Jianing
    Cunin, Pierre
    Bates, Samuel
    Morrison-Smith, Chevaun
    Nicholson, Benjamin
    Wong, Edmond
    El-Mufti, Leena
    Kann, Michael
    Bolling, Anna
    Fortin, Brooke
    Ventresca, Hayden
    Zhou, Wen
    Pardo, Santiago
    Kwock, Megan
    Hazra, Aditi
    Cheng, Leo
    Ahmad, Q. Rushdy
    Toombs, James A.
    Larson, Rebecca
    Pleskow, Haley
    Luo, Nell Meosky
    Samaha, Christina
    Pandya, Unnati M.
    De Silva, Pushpamali
    Zhou, Sally
    Ganhadeiro, Zakary
    Yohannes, Sara
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [8] Extrapulmonary manifestations of severe acute respiratory syndrome coronavirus-2 infection
    Rosen, Hugo R.
    O'Connell, Casey
    Nadim, Mitra K.
    DeClerck, Brittney
    Sheibani, Sarah
    DePasquale, Eugene
    Sanossian, Nerses
    Blodget, Emily
    Angell, Trevor
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (05) : 2645 - 2653
  • [9] Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection
    Fiel, M. Isabel
    El Jamal, Siraj M.
    Paniz-Mondolfi, Alberto
    Gordon, Ronald E.
    Reidy, Jason
    Bandovic, Jela
    Advani, Rashmi
    Kilaru, Saikiran
    Pourmand, Kamron
    Ward, Stephen
    Thung, Swan N.
    Schiano, Thomas
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2021, 11 (03): : 763 - 770
  • [10] Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2
    João Fernandes
    Peter Puhlmann
    Journal of NeuroVirology, 2021, 27 : 501 - 503